维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="BARNETT ME"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Immunologic and clinical re- sponses to parenteral immunotherapy in peanut anaphylaxisia study using igE and IgG4 immunoblot monitoring 显示文摘	Bullock Pal Barnett D Itowden ME	2005	Allergol Immuno- pathol(Madr)2005，33，5：	1
2	Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment显示文摘	HUTCHISON A J BARNETT ME KRAUSE R	2008	Nephron Clin Pract2008，110，1：	1
3	The PI3K/Akt pathway:recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors显示文摘	Lindsley CW Barnett SF Layton ME	2008	Curr Cancer Drug Targets2008，8，：	1
4	What5s in theBox- The effectiveness of a low-volume massive transfusionprotocol 显示文摘	Baysinger K Barnett ME Ott M	2016	Am Surg2016，82，：	1
5	Long-termefficacy and safety profile of lanthanum carbonate:Results for upto 6 years of treatment显示文摘	Hutchison AJ Barnett ME Krause R	2008	Nephron Clin Pract2008，110，1：	1
6	Lanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease stage 5 receiving hemodialysis 显示文摘	Hutchison A J Barnett ME Krause R	2009	Clin Nephrol2009，71，：	1
7	Cognitive function in stage 5chronic kidney disease patients on hemodialysis: no adverseeffects of lanthanum carbonate compared with standard phosphate- binder therapy显示文摘	Altmann P Barnett ME Finn WF	2007	Kidney Int2007，71，：	1
8	Gastrointestinal stromal tumours: origin and molecular oncology 显示文摘	Corless CL Barnett CM Heinrich Me	2011	Nat Rev Cancer2011，11，12：	1
9	Yellow fever vaccines and international travelers显示文摘	Barnett ED Wilder-Smith A Wilson ME	2008	Expert Rev Vaccines2008，7，5：	1
10	Long-term efficacy and safety profile of lanthanum carbonate: Results for up to 6 years of treatment 显示文摘	Hutchison AJ Barnett ME Krause R	2008	Nephron Clin Pract2008，110，1：	1
11	A practical synthesis of multitargeted antifolate LY231514显示文摘	Barnett C J Wilson TM Kobierski ME	1999	Org Proc Res Dev1999，3，3：	1
12	A practical dynthesis of multitargeted sntifolate LY231514 显示文摘	Barnett CJ Wilson TM Kobierski ME	1999	Org Process Res Dev1999，3，：	1
13	Immunologic and clinical re- spanses to parenteral immunotherapy in peanut anaphylaxisia study using IgE and IgG4 immunoblot monitoring 显示文摘	Bullock RJ Barnett D Howden ME	2005	Allergol Immuno- pathul(Madr)2005，33，5：	1
14	Long-term efficacy and safety profile of lanthanum carbonate:results for up to 6 years of treatment显示文摘	Hutchison AJ Barnett ME Krause R	2008	Nephrol Cli Pract2008，110，：	1
15	Revisiting cerebral thromboangiitis obliterans显示文摘	Hurelbrink CB Barnett Y Buckland ME	2012	J Neural Sci2012，317，12：	1
16	Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment 显示文摘	Hutehison AJ Barnett ME Krause R	2008	Nephron Clin Pract2008，110，1：	1
17	The PI3K/Akt pat- hway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors 显示文摘	Lindsley CW Barnett SF Layton ME	2008	Curr Cancer Drug Targets2008，8，1：	1
18	Cognitive function in stage 5 chronic kidney disease patients on hemddialysis: no adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy显示文摘	Altmann P Barnett ME Finn WF	2007	Kidney Int2007，71，：	1
19	Long term efficacy and safety profile of lanthanum carbonate:results for up to 6 years of treatment显示文摘	Hutchison AJ Barnett ME Krause R	2008	Nephron Clinical Pract2008，110，1：	1
20	The PI3K/Akt pathway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors显示文摘	Lindsley CW Barnett SF Layton ME	2008	Curr Cancer Drug Targets2008，8，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示